Green chemistry in the pharmaceutical industry / edited by Peter J. Dunn, Andrew S. Wells, and Michael T. Williams.
Material type: TextPublication details: Weinheim : Wiley-VCH, c2010.Description: xviii, 370 p. : ill. (some col.) ; 25 cmISBN:- 9783527324187 (hbk.) :
- 9783527324187 (Cloth)
- 338.476151 DUN
- HD9665.5
Item type | Current library | Call number | Copy number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|
Long Loan | TUS: Midlands, Main Library Athlone General Lending | 338.476151 DUN (Browse shelf(Opens below)) | 1 | Checked out | 15/12/2022 | 216816 | |
Long Loan | TUS: Midlands, Main Library Athlone General Lending | 338.476151 DUN (Browse shelf(Opens below)) | 1 | Available | 00213549 |
Includes bibliographical references and index.
1.Introduction to green chemistry, organic synthesis and pharmaceuticals -- 2.Green chemistry metrics -- 3.Solvent use and waste issues -- 4.Environmental and regulatory aspects -- 5.Synthesis of Sitagliptin, the active ingredient in Januvia and Janumet -- 6.The development of short, efficient, economic, and sustainable chemoenzymatic processes for statin side chains -- 7.The Taxol story - development of a green synthesis via plant cell fermentation -- 8.The development of a green, energy efficient, chemoenzymatic manufacturing process for Pregabalin -- 9.Green processes for peptide mimetic diabetic drugs -- 10.The development of an environmentally sustainable process for Radafaxine -- 11.Continuous processing the pharmaceutical industry -- 12.Preparative and industrial scale chromatography: green and integrated processes -- 13.Dynamic resolution of chiral amine pharmaceuticals: turning waste isomers into useful product -- 14.Green technologies in the genetic pharmaceutical industry -- 15.Environmental considerations in biologics manufacture -- 16.Future trends fo green chemistry in the pharmaceutical industry.
This work covers all aspects of green chemistry in the pharmaceutical industry, from simple molecules to complex proteins and from drug discovery to the fate of pharmaceuticals in the environment.